BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16601783)

  • 1. Galantamine antiacetylcholinesterase activity in rat brain influenced by L-carnitine.
    Svoboda Z; Kvĕtina J; Herink J; Bajgar J; Bartosová L; Palicka V; Zivný P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):335-7. PubMed ID: 16601783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of galantamine on acetylcholinesterase and butyrylcholinesterase activities in the presence of L-carnitine in rat selected brain and peripheral tissues.
    Svoboda Z; Kvetina J; Kunesová G; Herink J; Bajgar J; Bartosová L; Zivný P; Palicka V
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():183-6. PubMed ID: 17159811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of cholinesterase activities in the plasma and some tissues following administration of L-carnitine and galanthamine to rats.
    Bajgar J; Bartosova L; Fusek J; Svoboda Z; Herink J; Kvetina J; Palicka V; Zivny P; Blaha V
    Neurosci Lett; 2007 Jan; 411(3):212-6. PubMed ID: 17125927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A inhibits acetylcholinesterase activity in selected parts of the rat brain.
    Herink J; Krejcová G; Bajgar J; Svoboda Z; Kvĕtina J; Zivnú P; Palicka V
    Neurosci Lett; 2003 Mar; 339(3):251-3. PubMed ID: 12633900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.
    Bores GM; Huger FP; Petko W; Mutlib AE; Camacho F; Rush DK; Selk DE; Wolf V; Kosley RW; Davis L; Vargas HM
    J Pharmacol Exp Ther; 1996 May; 277(2):728-38. PubMed ID: 8627552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
    Geerts H; Guillaumat PO; Grantham C; Bode W; Anciaux K; Sachak S
    Brain Res; 2005 Feb; 1033(2):186-93. PubMed ID: 15694923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning.
    Woodruff-Pak DS; Vogel RW; Wenk GL
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):2089-94. PubMed ID: 11172080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum.
    Mulder J; Harkany T; Czollner K; Cremers TI; Keijser JN; Nyakas C; Luiten PG
    Behav Brain Res; 2005 Aug; 163(1):33-41. PubMed ID: 15951032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
    Hernandez CM; Gearhart DA; Parikh V; Hohnadel EJ; Davis LW; Middlemore ML; Warsi SP; Waller JL; Terry AV
    J Pharmacol Exp Ther; 2006 Feb; 316(2):679-94. PubMed ID: 16214877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine attenuates N,N-dimethyl hydrazine induced neoplastic colon damage by inhibiting acetylcholinesterase and bimodal regulation of nicotinic cholinergic neurotransmission.
    Sammi SR; Rawat JK; Raghav N; Kumar A; Roy S; Singh M; Gautam S; Yadav RK; Devi U; Pandey R; Kaithwas G
    Eur J Pharmacol; 2018 Jan; 818():174-183. PubMed ID: 29074413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking-based design and synthesis of galantamine-camphane hybrids as inhibitors of acetylcholinesterase.
    Stavrakov G; Philipova I; Zheleva-Dimitrova D; Valkova I; Salamanova E; Konstantinov S; Doytchinova I
    Chem Biol Drug Des; 2017 Nov; 90(5):709-718. PubMed ID: 28374576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiacetylcholinesterase activity of cyclosporine--a comparison of single and repeated administration and effect of 7-methoxytacrine.
    Herink J; Krejcová G; Bajgar J
    Acta Medica (Hradec Kralove); 2002; 45(4):145-7. PubMed ID: 12587781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine by low-dose galantamine in rats.
    Hahn B; Reneski CH; Lane M; Elmer GI; Pereira EFR
    Pharmacol Biochem Behav; 2020 Dec; 199():173043. PubMed ID: 33022302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia.
    Muthuraju S; Maiti P; Solanki P; Sharma AK; Amitabh ; Singh SB; Prasad D; Ilavazhagan G
    Behav Brain Res; 2009 Oct; 203(1):1-14. PubMed ID: 19446892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galantamine and Environmental Enrichment Enhance Cognitive Recovery after Experimental Traumatic Brain Injury But Do Not Confer Additional Benefits When Combined.
    de la Tremblaye PB; Bondi CO; Lajud N; Cheng JP; Radabaugh HL; Kline AE
    J Neurotrauma; 2017 Apr; 34(8):1610-1622. PubMed ID: 27806662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
    Enz A; Gentsch C
    Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of L-carnitine on acetylcholinesterase activity in aged rat brain.
    Rani PJ; Panneerselvam C
    J Gerontol A Biol Sci Med Sci; 2001 Mar; 56(3):B140-1. PubMed ID: 11253151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galantamine: a review of its use in Alzheimer's disease.
    Scott LJ; Goa KL
    Drugs; 2000 Nov; 60(5):1095-122. PubMed ID: 11129124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.
    Moss DE; Perez RG
    Curr Alzheimer Res; 2021; 18(13):1010-1022. PubMed ID: 34911424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galantamine is a novel post-exposure therapeutic against lethal VX challenge.
    Hilmas CJ; Poole MJ; Finneran K; Clark MG; Williams PT
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):166-73. PubMed ID: 19647007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.